Improving Lives Through Nuclear Medicine™

Jubilant Moments

Jubilant Moments

What is a Jubilant Moment?

A single special moment in time that defines the essence of who we are and what we do, along our journey to Improving Lives Through Nuclear Medicine.

  • June 11-15, 2021

    Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting

    Join us to see how we are advancing the field of Nuclear Medicine.

    The SNMMI Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The four-day event provides physicians, technologists, pharmacists, laboratory professionals, and scientists an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.

    Register today: 

  • May 9 - 11, 2021

    The International Conference on Nuclear Cardiology and Cardiac CT

    Join us to see how we are advancing Cardiac PET in Europe.

    This international conference has been a key scientific event for more than 20 years. It provides the opportunity for clinicians and scientists from all over the world to gather and learn about new advances in cardiac imaging and to exchange scientific ideas and experiences.

    Register before March 18 for reduced rates:

  • April 24 - 25, 2021

    39e Colloque de l’Association des médecins specialists en Médecine nucléaire du Québec

    39e Colloque de l’Association des médecins specialists en Médecine nucléaire du Québec

    For more information visit: 

  • April 9 - 11, 2021

    ASNC Cardiac PET Intensive Virtual Workshop

    Join us April 9 - 11 for the ASNC Cardiac PET Intensive Virtual Workshop, and see how we are advancing Cardiac PET Imaging.
    This is a case-based program uniquely formatted to your knowledge level to enhance interaction and learning. Don't miss this opportunity to access the workshop virtually from the convenience of your home or office at a great rate.
    Register today: 
  • April 9 - 10, 2021

    4th Annual Miami Thyroid Oncology Symposium

    We are proud to sponsor this unique program that focuses on the science and art of caring for patients with thyroid cancer.

    The two-day symposium will include workshops on Advances in Radioactive iodine (RAI) Theranostics and Advances in Molecular Diagnostics of Thyroid Nodules, as well as a plenary session that will bring together world renowned experts presenting and discussing the state of the Art in Thyroid cancer diagnosis and treatment.

    Register to attend today

  • March 6 - 7, 2021

    High Country Nuclear Medicine Conference

    The HCNMC features the experts from academia and industry, with leaders in medical specialties, regulatory agencies, and health care researchers to facilitate dialog and the exchange ideas needed to advance our field.

    Day one will be dedicated to CE and offer up to 7 hours of AMA/PRA via ACCME/VOICE sessions. Day two will focus on the traditional format of presentation, debate and collaboration.

    Take advantage of reduced registration rates today.

  • Ensuring all doses are delivered, so that our customers can focus on their patients

    Jubilant Moment #81

    For more than 25 years, our Radiopharmacies Division has been committed to delivering the right dose to our customers, exactly when they need it. And despite the ongoing pandemic, our pharmacy team, to date, has not missed delivering a single dose.

    This Moment celebrates the success of our COVID-19 Response Team’s efforts. This team works tirelessly around the clock to ensure all doses are delivered using an “all hands on deck” approach. We are enormously proud of their efforts.

  • The moment we realized just how essential our workers are to patient care.

    Jubilant Moment #75

    Amidst a year of unprecedented challenges, the Jubilant Radiopharma team has worked tirelessly to overcome the obstacles brought on by the pandemic. It is the worst of times that bring out the best in our people and it is these times that we are reminded how lucky we are to be able to serve our customers and the patients who rely on them. This would not be possible without every single one of our employees.

    In this Jubilant Moment we salute our team and all the essential workers who give patients hope each and every day.

  • Every day they ensure patients get the doses they need during the pandemic

    Jubilant Moment #55

    Jubilant Radiopharma’s mission is to Improve Lives Through Nuclear Medicine. A principal part of achieving our mission is providing the global Nuclear Medicine community with the best-in-class products and services.

    However, during the COVID-19 pandemic we have had to rethink the way we operate so that we could continue to provide the same level of service that our customers have grown to expect. Our Installation & Service Team remains available 24 hours a day, 7 days a week. They are navigating the ever changing travel restriction landscape across North America to get to customer sites, while ensuring that they protect themselves and the customers they are visiting. We are so proud of the team. They exemplify our company culture; always putting the customer first, so that our customers can focus on what’s important - their patients.

  • The day we raised the level of quality in Dallas

    Jubilant Moment #51

    Jubilant Radiopharma is making significant investments into its Radiopharmacies Division. Whether we are upgrading existing pharmacies or opening brand new locations, we are committed to strengthening our infrastructure so that we can better serve the nuclear medicine community with customized solutions to support our customers today, while advancing the practice of nuclear medicine for tomorrow.

    Our new state-of-art pharmacies are compliant with the newest regulatory standards and provide our customers with reliable and quality products for their patients. The task at hand is overwhelming, but our dedicated operations staff is committed to the patients we serve. We are so proud of their hard work and congratulate our Dallas team, at our newest state-of-the-art pharmacy, for a job well done!

  • The day industry came together to solidify the future of cardiac PET

    Jubilant Moment #15

    In the summer of 2019 the Centers for Medicare and Medicaid Services (CMS) published their proposed payments for Calendar 2020.  In the proposed rule for PFS payments they proposed significant reductions, as high as 80%, for office-based and free-standing center myocardial PET services. Understanding the negative impact this would have on patients across the country our Radiopharmaceuticals Division immediately began to work alongside other industry partners, medical societies and other advocacy groups to gather data in an effort to change the proposed payment reductions.

    It is our great pleasure to announce that CMS released the Final 2020 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System Rules (HOPPS) and the proposed payment reduction for 2020 had been reversed by CMS for calendar 2020.   This is an important win for PET cardiology and the patients who would have been affected by the reduction in coverage.


  • The first day she woke up pain free

    Jubilant Moment #5

    In October 2019, we announced that our Radiopharmacies Division signed an exclusive distribution agreement with                Q BioMed for Strontium-89 Chloride (Sr-89), a product indicated for the relief of bone pain in patients with painful skeletal metastases.   Jubilant Moment #5 was the day we distributed the first dose of Sr-89 to a patient who relies on us.

    Our vision is to Improve Lives Through Nuclear Medicine, it is the cornerstone of everything we do and shipping this does and helping this patient, is why we do what we do.  Bone metastases, often cause deep and endless pain. Palliative options for the control of this pain include analgesic support, cytotoxic chemotherapy and external-beam radiotherapy.   Sr-89 is used to help provide the patient with relief from the bone pain.

    The radioactive strontium is taken up in the bone cancer area and emits beta radiation directly into the metastases with little or no side-effects as compared to other palliative treatment options. In clinical trials, 75% of the cancer patients with metastatic bone disease who received Sr-89 experienced a reduction in pain, with 25%-30% of patients reporting complete pain relief.  The impact on the quality of life for patients is immeasurable.


We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.